Chapel Hill, NC, United States of America

David A Yeowell

USPTO Granted Patents = 16 (Patent Applications = 8)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 128(Granted Patents)

Location History:

San Francisco, CA (US) (2008 - 2015)
Chapel Hill, NC (US) (1979 - 2019)

Company Filing History:

Burroughs Wellcome Co.

patents

1 out of 2,893

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 1979-2019

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10272078 - Crystalline forms of a prolyl hydroxylase inhibitor (2019-04-30),

2. 10118897 - Crystalline forms of a prolyl hydroxylase inhibitor (2018-11-06),

3. 9918977 - Crystalline forms of a prolyl hydroxylase inhibitor (2018-03-20),

4. 9617218 - Crystalline forms of a prolyl hydroxylase inhibitor (2017-04-11),

5. 9371288 - Crystalline forms of a prolyl hydroxylase inhibitor (2016-06-21),

6. 9115085 - Crystalline forms of a prolyl hydroxylase inhibitor (2015-08-25),

7. 9034643 - Connective tissue growth factor antibodies (2015-05-19),

8. 8883823 - Crystalline forms of a prolyl hydroxylase inhibitor (2014-11-11),

9. 7871617 - Antibodies that bind to a portion of the VWC domain of connective tissue growth factor (2011-01-18),

10. 7405274 - Connective tissue growth factor antibodies (2008-07-29),

11. 4761418 - Novel compounds (1988-08-02),

12. 4701460 - Long duration neuromuscular blocking agents (1987-10-20),

13. 4500711 - Synthesis of leucovorin (1985-02-19),

14. 4491665 - Method of preparing isomers of bis isoquinolinium compounds (1985-01-01),

15. 4216319 - Synthesis of 2,4-diamino-5-benzylpyrimidines using benzyl cyanoacetal (1980-08-05),

Title: The Innovative Contributions of David A. Yeowell

Introduction

David A. Yeowell, an accomplished inventor based in Chapel Hill, NC, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, Yeowell continues to push the boundaries of innovation, particularly in the development of therapeutic agents aimed at combating various medical conditions.

Latest Patents

Among his latest achievements are the patents related to crystalline forms of a prolyl hydroxylase inhibitor. This disclosure emphasizes the crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid. The documentation not only details the unique process of preparing these forms but also outlines the pharmaceutical compositions and methods of use thereof. Such advancements have the potential to enhance the effectiveness of treatments associated with this inhibitor.

Career Highlights

David A. Yeowell has a rich career history, having worked with notable companies in the pharmaceutical sector. His tenure at Fibrogen, Inc. and Burroughs Wellcome Company provided him with invaluable experience and a platform to develop his innovative ideas. His diverse contributions to these organizations reflect his commitment to improving patient outcomes through scientific advancements.

Collaborations

Throughout his career, Yeowell has collaborated with numerous talented professionals, including Claudia Witschi and Jung Min Park. These partnerships have allowed for the exchange of ideas and the fostering of innovation within the pharmaceutical community, ultimately leading to significant research and development in the field.

Conclusion

David A. Yeowell's work exemplifies innovation and dedication in the realm of pharmaceuticals. His contributions, highlighted by his extensive patent portfolio, underscore the importance of continued research and collaboration in advancing medical science. As he progresses in his endeavors, the impact of his inventions hold promise for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.